Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Noninvasive vagus nerve stimulation in a primary care setting: effects on quality of life and utilization measures in multimorbidity patients with or without primary headache.

Strickland I, Mwamburi M, Davis S, Ward JCR, Day J, Tenaglia AT, Leibler EJ, Staats PS.

Am J Manag Care. 2018 Dec;24(24 Suppl):S517-S526.

2.

Serum biomarker profiles suggest that atopic dermatitis is a systemic disease.

Thijs JL, Strickland I, Bruijnzeel-Koomen CAFM, Nierkens S, Giovannone B, Knol EF, Csomor E, Sellman BR, Mustelin T, Sleeman MA, de Bruin-Weller MS, Herath A, Drylewicz J, May RD, Hijnen D.

J Allergy Clin Immunol. 2018 Apr;141(4):1523-1526. doi: 10.1016/j.jaci.2017.12.991. Epub 2018 Feb 2. No abstract available.

PMID:
29410314
3.

EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.

Thijs JL, Drylewicz J, Fiechter R, Strickland I, Sleeman MA, Herath A, May RD, Bruijnzeel-Koomen CAFM, Knol EF, Giovannone B, de Bruin-Weller MS, Nierkens S, Hijnen DJ.

J Allergy Clin Immunol. 2017 Dec;140(6):1703-1705. doi: 10.1016/j.jaci.2017.06.046. Epub 2017 Aug 16. No abstract available.

PMID:
28823810
4.

Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis.

Thijs JL, Strickland I, Bruijnzeel-Koomen CAFM, Nierkens S, Giovannone B, Csomor E, Sellman BR, Mustelin T, Sleeman MA, de Bruin-Weller MS, Herath A, Drylewicz J, May RD, Hijnen D.

J Allergy Clin Immunol. 2017 Sep;140(3):730-737. doi: 10.1016/j.jaci.2017.03.023. Epub 2017 Apr 13. Erratum in: J Allergy Clin Immunol. 2018 Aug;142(2):714.

PMID:
28412391
5.

Engineering the expression of an anti-interleukin-13 antibody through rational design and mutagenesis.

Popovic B, Gibson S, Senussi T, Carmen S, Kidd S, Slidel T, Strickland I, Jianqing X, Spooner J, Lewis A, Hudson N, Mackenzie L, Keen J, Kemp B, Hardman C, Hatton D, Wilkinson T, Vaughan T, Lowe D.

Protein Eng Des Sel. 2017 Apr 1;30(4):303-311. doi: 10.1093/protein/gzx001.

PMID:
28130326
6.

The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.

Hepburn L, Hijnen DJ, Sellman BR, Mustelin T, Sleeman MA, May RD, Strickland I.

Br J Dermatol. 2017 Jul;177(1):63-71. doi: 10.1111/bjd.15139. Epub 2017 Jun 11. Review.

PMID:
27779765
7.

Optimizing Transgene Configuration and Protein Fusions to Maximize Dopamine Production for the Gene Therapy of Parkinson's Disease.

Stewart HJ, Ralph GS, Fong-Wong L, Strickland I, McCloskey L, Barnes L, Blount I, Wells O, Truran CJ, Kingsman AJ, Palfi S, Mitrophanous KA.

Hum Gene Ther Clin Dev. 2016 Sep;27(3):100-10. doi: 10.1089/humc.2016.056. Epub 2016 Jul 28.

PMID:
27470285
8.

Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13.

Urbach C, Gordon NC, Strickland I, Lowne D, Joberty-Candotti C, May R, Herath A, Hijnen D, Thijs JL, Bruijnzeel-Koomen CA, Minter RR, Hollfelder F, Jermutus L.

Chem Biol. 2015 Nov 19;22(11):1442-1452. doi: 10.1016/j.chembiol.2015.09.013. Epub 2015 Nov 5.

9.

Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell-mediated antibody-dependent cellular cytotoxicity.

Rudnicka D, Oszmiana A, Finch DK, Strickland I, Schofield DJ, Lowe DC, Sleeman MA, Davis DM.

Blood. 2013 Jun 6;121(23):4694-702. doi: 10.1182/blood-2013-02-482570. Epub 2013 Apr 23.

PMID:
23613524
10.

The kinase PDK1 is essential for B-cell receptor mediated survival signaling.

Park SG, Long M, Kang JA, Kim WS, Lee CR, Im SH, Strickland I, Schulze-Luehrmann J, Hayden MS, Ghosh S.

PLoS One. 2013;8(2):e55378. doi: 10.1371/journal.pone.0055378. Epub 2013 Feb 5.

11.

Axotomy-induced miR-21 promotes axon growth in adult dorsal root ganglion neurons.

Strickland IT, Richards L, Holmes FE, Wynick D, Uney JB, Wong LF.

PLoS One. 2011;6(8):e23423. doi: 10.1371/journal.pone.0023423. Epub 2011 Aug 10.

12.

A stable producer cell line for the manufacture of a lentiviral vector for gene therapy of Parkinson's disease.

Stewart HJ, Fong-Wong L, Strickland I, Chipchase D, Kelleher M, Stevenson L, Thoree V, McCarthy J, Ralph GS, Mitrophanous KA, Radcliffe PA.

Hum Gene Ther. 2011 Mar;22(3):357-69. doi: 10.1089/hum.2010.142. Epub 2011 Feb 10.

PMID:
21070114
13.

Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor.

Long M, Park SG, Strickland I, Hayden MS, Ghosh S.

Immunity. 2009 Dec 18;31(6):921-31. doi: 10.1016/j.immuni.2009.09.022.

14.

Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes.

Jimi E, Strickland I, Voll RE, Long M, Ghosh S.

Immunity. 2008 Oct 17;29(4):523-37. doi: 10.1016/j.immuni.2008.08.010.

15.

Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13.

Chapoval SP, Al-Garawi A, Lora JM, Strickland I, Ma B, Lee PJ, Homer RJ, Ghosh S, Coyle AJ, Elias JA.

J Immunol. 2007 Nov 15;179(10):7030-41.

16.

Changes in the expression of NaV1.7, NaV1.8 and NaV1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain.

Strickland IT, Martindale JC, Woodhams PL, Reeve AJ, Chessell IP, McQueen DS.

Eur J Pain. 2008 Jul;12(5):564-72. Epub 2007 Oct 18.

PMID:
17950013
17.

Pressure application measurement (PAM): a novel behavioural technique for measuring hypersensitivity in a rat model of joint pain.

Barton NJ, Strickland IT, Bond SM, Brash HM, Bate ST, Wilson AW, Chessell IP, Reeve AJ, McQueen DS.

J Neurosci Methods. 2007 Jun 15;163(1):67-75. Epub 2007 Feb 20.

PMID:
17383008
18.

Use of cell permeable NBD peptides for suppression of inflammation.

Strickland I, Ghosh S.

Ann Rheum Dis. 2006 Nov;65 Suppl 3:iii75-82. Review.

19.

Investigation of mechanisms underlying the T-cell response to the hapten 2,4-dinitrochlorobenzene.

Pickard C, Smith AM, Cooper H, Strickland I, Jackson J, Healy E, Friedmann PS.

J Invest Dermatol. 2007 Mar;127(3):630-7. Epub 2006 Sep 28.

20.

Intravenous hyoscine as a premedication for colonoscopy: a randomized double-blind controlled trial.

Yoong KY, Perkin D, Portal J, Strickland I, Heymann T.

Endoscopy. 2004 Aug;36(8):720-2.

PMID:
15280979
21.

NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis.

Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, Iglehart JD.

Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10137-42. Epub 2004 Jun 25.

22.

Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks.

Smoot LM, McCormick JK, Smoot JC, Hoe NP, Strickland I, Cole RL, Barbian KD, Earhart CA, Ohlendorf DH, Veasy LG, Hill HR, Leung DY, Schlievert PM, Musser JM.

Infect Immun. 2002 Dec;70(12):7095-104.

23.

Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY.

N Engl J Med. 2002 Oct 10;347(15):1151-60.

24.

Increased glucocorticoid receptor Beta expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype.

Hauk PJ, Goleva E, Strickland I, Vottero A, Chrousos GP, Kisich KO, Leung DY.

Am J Respir Cell Mol Biol. 2002 Sep;27(3):361-7.

PMID:
12204899
25.

NP roles in women's health management.

Strickland I.

AWHONN Lifelines. 2002 Jun-Jul;6(3):191-2. No abstract available.

PMID:
12078558
26.

Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis.

Ong PY, Hamid QA, Travers JB, Strickland I, Al Kerithy M, Boguniewicz M, Leung DY.

J Immunol. 2002 Jan 1;168(1):505-10.

27.

Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin.

Cho SH, Strickland I, Boguniewicz M, Leung DY.

J Allergy Clin Immunol. 2001 Aug;108(2):269-74.

PMID:
11496245
28.

Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model.

Cho SH, Strickland I, Tomkinson A, Fehringer AP, Gelfand EW, Leung DY.

J Invest Dermatol. 2001 May;116(5):658-63.

29.

High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids.

Strickland I, Kisich K, Hauk PJ, Vottero A, Chrousos GP, Klemm DJ, Leung DY.

J Exp Med. 2001 Mar 5;193(5):585-93.

30.

The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases.

Leung DY, Hauk P, Strickland I, Travers JB, Norris DA.

Br J Dermatol. 1998 Dec;139 Suppl 53:17-29. Review.

PMID:
9990409
31.

Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis.

Strickland I, Hauk PJ, Trumble AE, Picker LJ, Leung DY.

J Invest Dermatol. 1999 Feb;112(2):249-53.

32.
33.

Comparison of changes in endothelial adhesion molecule expression following UVB irradiation of skin and a human dermal microvascular cell line (HMEC-1).

Rhodes LE, Joyce M, West DC, Strickland I, Friedmann PS.

Photodermatol Photoimmunol Photomed. 1996 Jun;12(3):114-21.

PMID:
8956361
34.

Effect of biomaterial surface charge on the inflammatory response: evaluation of cellular infiltration and TNF alpha production.

Hunt JA, Flanagan BF, McLaughlin PJ, Strickland I, Williams DF.

J Biomed Mater Res. 1996 May;31(1):139-44.

PMID:
8731158
35.

Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis.

Tan BB, Weald D, Strickland I, Friedmann PS.

Lancet. 1996 Jan 6;347(8993):15-8.

PMID:
8531541
36.

Pathogenesis and management of atopic dermatitis.

Friedmann PS, Tan BB, Musaba E, Strickland I.

Clin Exp Allergy. 1995 Sep;25(9):799-806. Review. No abstract available. Erratum in: Clin Exp Allergy 1996 Apr;26(4):479-81.

PMID:
8564717
37.

Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.

Friedmann PS, Strickland I, Pirmohamed M, Park BK.

Arch Dermatol. 1994 May;130(5):598-604.

PMID:
8179341
38.

Early time course of recruitment of immune surveillance in human skin after chemical provocation.

Friedmann PS, Strickland I, Memon AA, Johnson PM.

Clin Exp Immunol. 1993 Mar;91(3):351-6.

39.

The therapeutic equivalence of oral and intravenous iron in renal dialysis patients.

Strickland ID, Chaput de Saintonge DM, Boulton FE, Francis B, Roubikova J, Waters JI.

Clin Nephrol. 1977 Feb;7(2):55-7.

PMID:
321170
40.

Letter: Iron treatment of dialysis patients.

Chaput De Saintonge DM, Boulton FE, Strickland ID.

Br Med J. 1975 May 10;2(5966):337. No abstract available.

41.

A double-blind controlled trial of 'Gaviscon' in patients with symptomatic gastro-oesophageal reflux.

Barnardo DE, Lancaster-Smith M, Strickland ID, Wright JT.

Curr Med Res Opin. 1975;3(6):388-91.

PMID:
1183220
42.

A controlled trial of practolol in mild hypertension.

Chaput de Saintonge DM, Roberts CJ, Strickland ID, Vere DW.

Br J Clin Pharmacol. 1974 Oct;1(5):375-8.

43.

A trial of oral iron in dialysis patients.

Strickland ID, Chaput de Saintonge DM, Boulton FE, Brain AJ, Goodwin FJ, Marsh FP, Zychova Z.

Clin Nephrol. 1974 Jan-Feb;2(1):13-7. No abstract available.

PMID:
4595978
44.

Autoantibodies in adult coeliac disease.

Lancaster-Smith MJ, Strickland ID.

Lancet. 1971 Jun 12;1(7711):1244. No abstract available.

PMID:
4103107
45.

Coeliac disease and diffuse interstitial lung disease.

Smith MJ, Benson MK, Strickland ID.

Lancet. 1971 Mar 6;1(7697):473-5. No abstract available.

PMID:
4100350
46.

Coeliac disease and schizophrenia.

Lancaster-Smith MJ, Strickland I.

Lancet. 1970 Nov 21;2(7682):1090-1. No abstract available.

PMID:
4098389
47.

Azathioprine: a controlled, double-blind trial in rheumatoid arthritis.

Barnes CG, Currey HL, Dunne JF, Hazleman B, Mason RM, Strickland ID.

Ann Rheum Dis. 1969 May;28(3):327-8. No abstract available.

48.

Azathioprine in rheumatoid arthritis.

Mason M, Currey HL, Barnes CG, Dunne JF, Hazleman BL, Strickland ID.

Br Med J. 1969 Feb 15;1(5641):420-2.

Supplemental Content

Loading ...
Support Center